These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15985940)

  • 1. Perception of depot antipsychotics by mental health professionals.
    Lambert T; Brennan A; Castle D; Kelly DL; Conley RR
    J Psychiatr Pract; 2003 May; 9(3):252-60. PubMed ID: 15985940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
    Patel MX; Nikolaou V; David AS
    Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic depot medication and attitudes of community psychiatric nurses.
    Patel MX; DE Zoysa N; Baker D; David AS
    J Psychiatr Ment Health Nurs; 2005 Apr; 12(2):237-44. PubMed ID: 15788043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.
    Altamura AC; Sassella F; Santini A; Montresor C; Fumagalli S; Mundo E
    Drugs; 2003; 63(5):493-512. PubMed ID: 12600227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing.
    Patel MX; De Zoysa N; Bernadt M; David A
    J Psychopharmacol; 2009 Sep; 23(7):789-96. PubMed ID: 18583438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders.
    Quraishi S; David A
    Cochrane Database Syst Rev; 2000; (2):CD001470. PubMed ID: 10796442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are depot antipsychotics more coercive than tablets? The patient's perspective.
    Patel MX; de Zoysa N; Bernadt M; Bindman J; David AS
    J Psychopharmacol; 2010 Oct; 24(10):1483-9. PubMed ID: 19304865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' and clinicians' attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosis.
    Kirschner M; Theodoridou A; Fusar-Poli P; Kaiser S; Jäger M
    Ther Adv Psychopharmacol; 2013 Apr; 3(2):89-99. PubMed ID: 24167680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions on efficacy and side effects of conventional depot antipsychotics (CDA) and atypical depot antipsychotics (ADA): Psychiatrists versus patients in Hong Kong.
    Tsang HW; Fong MW; Fung KM; Chung RC
    Int J Psychiatry Clin Pract; 2010 Mar; 14(1):23-32. PubMed ID: 24917229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot bromperidol decanoate for schizophrenia.
    Wong D; Adams CE; David A; Quraishi SN
    Cochrane Database Syst Rev; 2004; (3):CD001719. PubMed ID: 15266450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective experience and mental side-effects of antipsychotic treatment.
    Gerlach J; Larsen EB
    Acta Psychiatr Scand Suppl; 1999; 395():113-7. PubMed ID: 10225340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-sectional study of patients' perspectives on adherence to antipsychotic medication: depot versus oral.
    Patel MX; de Zoysa N; Bernadt M; David AS
    J Clin Psychiatry; 2008 Oct; 69(10):1548-56. PubMed ID: 19192437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting injectable antipsychotics in the elderly: guidelines for effective use.
    Masand PS; Gupta S
    Drugs Aging; 2003; 20(15):1099-110. PubMed ID: 14651433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.
    Möller HJ
    Drugs; 2007; 67(11):1541-66. PubMed ID: 17661527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.